We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HEIO:EURONEXT AMSTERDAMHeineken Holding N.V. Analysis

Data as of 2026-08-22 - not real-time

€67.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Heineken Holding N.V. trades at €67.80, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it lost 1.0%. Momentum indicators put RSI at 39.8 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at €67.20 and resistance at €75.35.
Valuation screens as fair, on a P/E of 16.6 with no clean sector comparison available. Revenue is contracting at 2.8% on a 3.3% profit margin. The 2.83% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 23.7%, a beta of -0.08 and a maximum drawdown of 19.0%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

Heineken Holding N.V. Reports Transactions Under Its Current Share Buyback Programme. <b Heineken Holding N.V. reports...Heineken Holding N.V. reports transactions under its currentAmsterdam, 5 August 2026 HEINEKEN HOLDING N.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 64.60
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 64.60
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Revenue contracting at -2.8%
  • P/E ratio of 16.6
  • Dividend yield of 2.83%

Key Metrics & Analysis

Financial Health

Revenue Growth-2.80%
Profit Margin3.31%
P/E Ratio16.6
ROE10.08%
ROA4.44%
Debt/Equity94.81
P/B Ratio2.2
Op. Cash Flow€5.0B
Free Cash Flow€2.2B

Technical Analysis

TrendBullish
RSI39.8
Support€67.20
Resistance€75.35
MA 20€71.15
MA 50€69.19
MA 200€64.60
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value€49.66
GradeFair
TypeBlend
Dividend Yield2.83%

Risk Assessment

Beta-0.08
Volatility23.68%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.